Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-24-00152
Lilin Zhao, Yaqi Zhang, Qian Huang, Ting Zhang
Sonodynamic therapy has emerged as a novel non-invasive treatment for cancer with limited single effects. To achieve optimal therapeutic efficacy, sonodynamic therapy frequently needs to be combined with other therapeutic strategies. By exploiting the biological properties of specific gas molecules, gas therapy is an emerging tumor treatment that exerts direct or indirect inhibitory effects on tumor cells. This review systematically examines the rationales, methodologies, and outcomes of sonodynamic therapy and gas therapy combinatorial strategies for malignant tumors. There is a synergistic effect between sonodynamic therapy and gas therapy in tumor treatment. The ultrasound-induced cavitation enhances tissue permeability for improved gas delivery, while gas molecules concurrently sensitize sonodynamic reactions and ameliorate tumor hypoxia. The interaction significantly enhances the therapeutic effect of tumors. Moreover, the combination of sonodynamic therapy with other therapeutic modalities can significantly enhance the anti-tumor efficacy, improve the therapeutic precision and safety, while improve the tumor microenvironment. This combined treatment strategy can also reduce side effects and has a broad clinical application perspective.
{"title":"Comprehensive strategy of sonodynamic therapy and gas therapy on tumor treatment.","authors":"Lilin Zhao, Yaqi Zhang, Qian Huang, Ting Zhang","doi":"10.4103/mgr.MEDGASRES-D-24-00152","DOIUrl":"10.4103/mgr.MEDGASRES-D-24-00152","url":null,"abstract":"<p><p>Sonodynamic therapy has emerged as a novel non-invasive treatment for cancer with limited single effects. To achieve optimal therapeutic efficacy, sonodynamic therapy frequently needs to be combined with other therapeutic strategies. By exploiting the biological properties of specific gas molecules, gas therapy is an emerging tumor treatment that exerts direct or indirect inhibitory effects on tumor cells. This review systematically examines the rationales, methodologies, and outcomes of sonodynamic therapy and gas therapy combinatorial strategies for malignant tumors. There is a synergistic effect between sonodynamic therapy and gas therapy in tumor treatment. The ultrasound-induced cavitation enhances tissue permeability for improved gas delivery, while gas molecules concurrently sensitize sonodynamic reactions and ameliorate tumor hypoxia. The interaction significantly enhances the therapeutic effect of tumors. Moreover, the combination of sonodynamic therapy with other therapeutic modalities can significantly enhance the anti-tumor efficacy, improve the therapeutic precision and safety, while improve the tumor microenvironment. This combined treatment strategy can also reduce side effects and has a broad clinical application perspective.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"269-276"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00127
Solpa Lee, Pratiksha Diwe, Tae Ho Lim, Yongwoo Jang
{"title":"Emerging electronic deodorization technologies for human odor management.","authors":"Solpa Lee, Pratiksha Diwe, Tae Ho Lim, Yongwoo Jang","doi":"10.4103/mgr.MEDGASRES-D-25-00127","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00127","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"311-312"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00096
Zhen Liu, Ainikaer Abulaiti, Yan Zhao, Junting Zang, Guohua Li, Li Shu, Paerhati Wahafu, Maihemuti Yakufu
JOURNAL/mgres/04.03/01612956-202609000-00002/figure1/v/2026-01-06T135433Z/r/image-tiff Nitric oxide, a pivotal endogenous signaling molecule, plays crucial roles in cardiovascular regulation, immune response, and neuromodulation. The rapid advancement of artificial intelligence technologies offers novel approaches to optimize real-time nitric oxide monitoring, dosing regimens, and toxicity prediction. Current interdisciplinary research on the artificial intelligence-driven nitric oxide intersection remains fragmented, with a lack of systematic investigations into knowledge architecture, technological evolution, and translational barriers. This study addressed this critical gap by presenting the knowledge graph-based analysis of artificial intelligence-driven nitric oxide system. A total of 384 relevant articles (2005-2024) were retrieved in the Web of Science Core Collection and analyzed using CiteSpace, VOSviewer, and Bibliometrix R package. Annual publications demonstrated a biphasic growth, accelerating after 2017 in tandem with breakthroughs in artificial intelligence architectures. Although China and the United States were dominated in this field, international collaborations exhibited a core-periphery structure. Research themes predominantly focused on cardiovascular and respiratory diseases, with underdeveloped applications in neuroimmunology and infectious diseases. Highly cited literature that emphasized photodynamic therapy and disease risk assessment revealed insufficient integration between artificial intelligence algorithms and fundamental nitric oxide mechanisms. Keyword evolution analysis identified a paradigm shift from traditional mechanisms (e.g., "blood pressure," "inflammation") to technology-driven approaches (e.g., "machine learning, " "deep learning"). Clinical translation has faced challenges, including data heterogeneity, algorithm interpretability, and deficiencies in multicenter validation. This pioneering study systematically delineates the knowledge framework and translational bottlenecks in artificial intelligence-driven nitric oxide convergence. Future research should prioritize artificial intelligence modeling of nitric oxide dynamic metabolism, the development of explainable algorithms, and prospective clinical trials to bridge the laboratory-to-clinic gap.
一氧化氮是一种重要的内源性信号分子,在心血管调节、免疫应答和神经调节中起着重要作用。人工智能技术的快速发展为优化实时一氧化氮监测、给药方案和毒性预测提供了新的方法。目前,人工智能驱动的一氧化氮交叉路口的跨学科研究仍然是碎片化的,缺乏对知识架构、技术进化和转化障碍的系统调查。本研究通过提出基于知识图的人工智能驱动一氧化氮系统分析解决了这一关键差距。利用CiteSpace、VOSviewer和Bibliometrix R软件包对Web of Science核心馆藏2005-2024年的384篇相关文献进行分析。年度出版物呈现双阶段增长,2017年之后随着人工智能架构的突破而加速增长。尽管中国和美国在这一领域占据主导地位,但国际合作呈现出核心-边缘结构。研究主题主要集中在心血管和呼吸系统疾病,在神经免疫学和传染病方面的应用不发达。强调光动力疗法和疾病风险评估的高引用文献表明,人工智能算法与一氧化氮基本机制之间的整合不足。关键词进化分析确定了从传统机制(如“血压”、“炎症”)到技术驱动方法(如“机器学习”、“深度学习”)的范式转变。临床翻译面临着挑战,包括数据异质性、算法可解释性和多中心验证的不足。这项开创性的研究系统地描述了人工智能驱动的一氧化氮收敛的知识框架和转化瓶颈。未来的研究应优先考虑一氧化氮动态代谢的人工智能建模、可解释算法的发展和前瞻性临床试验,以弥合实验室到临床的差距。
{"title":"Clinical applications of artificial intelligence-driven nitric oxide: a bibliometric and scientific mapping analysis.","authors":"Zhen Liu, Ainikaer Abulaiti, Yan Zhao, Junting Zang, Guohua Li, Li Shu, Paerhati Wahafu, Maihemuti Yakufu","doi":"10.4103/mgr.MEDGASRES-D-25-00096","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00096","url":null,"abstract":"<p><p>JOURNAL/mgres/04.03/01612956-202609000-00002/figure1/v/2026-01-06T135433Z/r/image-tiff Nitric oxide, a pivotal endogenous signaling molecule, plays crucial roles in cardiovascular regulation, immune response, and neuromodulation. The rapid advancement of artificial intelligence technologies offers novel approaches to optimize real-time nitric oxide monitoring, dosing regimens, and toxicity prediction. Current interdisciplinary research on the artificial intelligence-driven nitric oxide intersection remains fragmented, with a lack of systematic investigations into knowledge architecture, technological evolution, and translational barriers. This study addressed this critical gap by presenting the knowledge graph-based analysis of artificial intelligence-driven nitric oxide system. A total of 384 relevant articles (2005-2024) were retrieved in the Web of Science Core Collection and analyzed using CiteSpace, VOSviewer, and Bibliometrix R package. Annual publications demonstrated a biphasic growth, accelerating after 2017 in tandem with breakthroughs in artificial intelligence architectures. Although China and the United States were dominated in this field, international collaborations exhibited a core-periphery structure. Research themes predominantly focused on cardiovascular and respiratory diseases, with underdeveloped applications in neuroimmunology and infectious diseases. Highly cited literature that emphasized photodynamic therapy and disease risk assessment revealed insufficient integration between artificial intelligence algorithms and fundamental nitric oxide mechanisms. Keyword evolution analysis identified a paradigm shift from traditional mechanisms (e.g., \"blood pressure,\" \"inflammation\") to technology-driven approaches (e.g., \"machine learning, \" \"deep learning\"). Clinical translation has faced challenges, including data heterogeneity, algorithm interpretability, and deficiencies in multicenter validation. This pioneering study systematically delineates the knowledge framework and translational bottlenecks in artificial intelligence-driven nitric oxide convergence. Future research should prioritize artificial intelligence modeling of nitric oxide dynamic metabolism, the development of explainable algorithms, and prospective clinical trials to bridge the laboratory-to-clinic gap.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"194-204"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00161
Shijun Wang, Sicen Wan, Xu Zhang, Ming Sun, Hongru Li, Gang Chen, Jiahe Wang, Xiang Li
<p><p>FactsNitric oxide (NO) exhibits dual roles in stroke pathophysiology, serving as both a neuroprotective agent through vasodilation and anti-thrombotic effects, and a neurotoxic mediator via oxidative stress and glutamate excitotoxicity, depending on its concentration, timing, and source.NO has been shown to play a critical role in improving outcomes after stroke in experimental studies.The efficacy of NO-based interventions varies depending on stroke type and timing. The administration of NO and its donors in stroke therapy should be flexibly integrated based on the temporal dynamics of endogenous NO following stroke onset. Inappropriate timing of medication may exacerbate the patient's condition post-stroke.Open questionsWhat are the precise molecular mechanisms underlying the concentration-dependent dual effects of NO in different stroke subtypes, and how can we selectively enhance its beneficial while suppressing its detrimental actions?How can we optimize the timing and dosing of NO donors across heterogeneous stroke populations, especially in intracerebral hemorrhage where clinical evidence is notably scarce?Can NO-based interventions be safely translated from animal models to human patients? The limited number of clinical studies necessitates larger-scale trials to confirm efficacy and safety in diverse patient populations.What are the long-term neurological consequences of NO administration? While short-term benefits have been observed, the potential for delayed adverse effects or unintended impacts on brain function remains underexplored. Nitric oxide is a gas molecule that serves as a signaling molecule in mammals, regulating the relaxation and contraction of vascular, thereby modulating local blood flow. Stroke encompasses both hemorrhagic and ischemic subtypes, with hemorrhagic strokes further classified into subarachnoid and intracerebral hemorrhages. The vasodilatory effects of nitric oxide and its derivatives have been confirmed in both peripheral and central vascular diseases. Additionally, animal studies have demonstrated that exogenous supplementation of nitric oxide or its donors has beneficial effects on stroke. We systematically reviewed the existing research on the relationship between nitric oxide donors and stroke, and elaborated on the pathophysiological processes in which nitric oxide is involved in different types of strokes. Given the significant differences in the concentration and temporal effects of nitric oxide in various types of strokes and their pathophysiological processes, the optimal timing for exogenous nitric oxide intervention under different conditions was analyzed to enhance clinical awareness regarding the treatment with nitric oxide and its donors. Future research can place greater emphasis on the development of novel nitric oxide donors and their diverse administration routes to further optimize treatment outcomes for stroke. This review underscores the limited progress in the clinical translatio
{"title":"Therapeutic potential of nitric oxide and its donors in hemorrhagic and ischemic stroke: a systematic review.","authors":"Shijun Wang, Sicen Wan, Xu Zhang, Ming Sun, Hongru Li, Gang Chen, Jiahe Wang, Xiang Li","doi":"10.4103/mgr.MEDGASRES-D-25-00161","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00161","url":null,"abstract":"<p><p>FactsNitric oxide (NO) exhibits dual roles in stroke pathophysiology, serving as both a neuroprotective agent through vasodilation and anti-thrombotic effects, and a neurotoxic mediator via oxidative stress and glutamate excitotoxicity, depending on its concentration, timing, and source.NO has been shown to play a critical role in improving outcomes after stroke in experimental studies.The efficacy of NO-based interventions varies depending on stroke type and timing. The administration of NO and its donors in stroke therapy should be flexibly integrated based on the temporal dynamics of endogenous NO following stroke onset. Inappropriate timing of medication may exacerbate the patient's condition post-stroke.Open questionsWhat are the precise molecular mechanisms underlying the concentration-dependent dual effects of NO in different stroke subtypes, and how can we selectively enhance its beneficial while suppressing its detrimental actions?How can we optimize the timing and dosing of NO donors across heterogeneous stroke populations, especially in intracerebral hemorrhage where clinical evidence is notably scarce?Can NO-based interventions be safely translated from animal models to human patients? The limited number of clinical studies necessitates larger-scale trials to confirm efficacy and safety in diverse patient populations.What are the long-term neurological consequences of NO administration? While short-term benefits have been observed, the potential for delayed adverse effects or unintended impacts on brain function remains underexplored. Nitric oxide is a gas molecule that serves as a signaling molecule in mammals, regulating the relaxation and contraction of vascular, thereby modulating local blood flow. Stroke encompasses both hemorrhagic and ischemic subtypes, with hemorrhagic strokes further classified into subarachnoid and intracerebral hemorrhages. The vasodilatory effects of nitric oxide and its derivatives have been confirmed in both peripheral and central vascular diseases. Additionally, animal studies have demonstrated that exogenous supplementation of nitric oxide or its donors has beneficial effects on stroke. We systematically reviewed the existing research on the relationship between nitric oxide donors and stroke, and elaborated on the pathophysiological processes in which nitric oxide is involved in different types of strokes. Given the significant differences in the concentration and temporal effects of nitric oxide in various types of strokes and their pathophysiological processes, the optimal timing for exogenous nitric oxide intervention under different conditions was analyzed to enhance clinical awareness regarding the treatment with nitric oxide and its donors. Future research can place greater emphasis on the development of novel nitric oxide donors and their diverse administration routes to further optimize treatment outcomes for stroke. This review underscores the limited progress in the clinical translatio","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"241-257"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00075
Pan Yang, Yadi Wang, Xueling Li, Junhong Lü
Conventional antibiotic therapies often fail to eradicate biofilms, which can lead to persistent infections and significant clinical challenges. Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges. This review first highlights gas signaling in bacterial biofilms. It then goes on to list four types of gas therapy in detail: photothermal-enhanced gas therapy, photodynamic-activated gas therapy, micro/nanobubble-mediated gas therapy, and gas-based synergistic therapy. Their potential applications and future directions are also fully discussed. Due to its unique bioactivity, low resistance, and synergy with existing treatments, gas therapy has demonstrated significant potential in the prevention and treatment of biofilm-associated infections. However, overcoming delivery challenges, validating efficacy in large-scale trials, and developing standardized protocols are essential for its clinical translation. Future efforts should prioritize the integration of nanotechnology and mechanistic studies to unlock broader therapeutic utility.
{"title":"Research and application of gas therapy in preventing biofilm associated infections.","authors":"Pan Yang, Yadi Wang, Xueling Li, Junhong Lü","doi":"10.4103/mgr.MEDGASRES-D-25-00075","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00075","url":null,"abstract":"<p><p>Conventional antibiotic therapies often fail to eradicate biofilms, which can lead to persistent infections and significant clinical challenges. Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges. This review first highlights gas signaling in bacterial biofilms. It then goes on to list four types of gas therapy in detail: photothermal-enhanced gas therapy, photodynamic-activated gas therapy, micro/nanobubble-mediated gas therapy, and gas-based synergistic therapy. Their potential applications and future directions are also fully discussed. Due to its unique bioactivity, low resistance, and synergy with existing treatments, gas therapy has demonstrated significant potential in the prevention and treatment of biofilm-associated infections. However, overcoming delivery challenges, validating efficacy in large-scale trials, and developing standardized protocols are essential for its clinical translation. Future efforts should prioritize the integration of nanotechnology and mechanistic studies to unlock broader therapeutic utility.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"263-268"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00094
Olga V Kosmachevskaya, Alexey F Topunov
{"title":"Protein-bound nitrosyl iron complexes: long-lived physiological form of nitric oxide.","authors":"Olga V Kosmachevskaya, Alexey F Topunov","doi":"10.4103/mgr.MEDGASRES-D-25-00094","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00094","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"307-308"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-09-01Epub Date: 2026-01-06DOI: 10.4103/mgr.MEDGASRES-D-25-00088
Pedro Iván Arias-Vázquez, Rosa Giannina Castillo-Avila, Karen Hernández-Gil, Mauro Nicolás Guzzardo, Duilio Román Guzzardo
The only intra-articular injections recommended by international guidelines for the treatment of knee osteoarthritis are injections of corticosteroids and hyaluronic acid; nonetheless, other substances including ozone, dextrose and platelet-rich plasma are also used in clinical. Intra-articular injections of ozone have been reported to have anti-inflammatory mechanisms and clinical benefits similar to intra-articular injections of corticosteroids in patients with knee osteoarthritis; however, this treatment has not been evaluated in a meta-analysis. The objective of this review is to evaluate the effectiveness of intra-articular injections of ozone for reducing pain and improving function in individuals with knee osteoarthritis when compared with intra-articular injections of corticosteroids. An online search was performed using the electronic databases PubMed, EMBASE, Central Cochrane and Web of Science, for controlled clinical trials that compared intra-articular injections of ozone and intra-articular injections of corticosteroid in the treatment of knee osteoarthritis. Seven clinical trials were included in this review, gathering 409 individuals with knee osteoarthritis. In the pooled analysis, ozone injections were found to be more effective in reducing pain in the short and medium terms than corticosteroids injections. Similarly, function improvement in the medium term was observed in favor of ozone injections. Our results suggest that ozone injections represent a good alternative to corticosteroids injections for reducing pain in the short and medium terms in individuals with knee osteoarthritis. Nonetheless, definitive conclusions could not be drawn due to the limited quality of the included studies. Better quality clinical trials are needed to strengthen the evidence and confirm these results.
治疗膝骨关节炎的国际指南中唯一推荐的关节内注射是皮质类固醇和透明质酸注射;尽管如此,其他物质包括臭氧、葡萄糖和富血小板血浆也用于临床。据报道,在膝关节骨关节炎患者中,关节内注射臭氧具有抗炎机制和类似于关节内注射皮质类固醇的临床益处;然而,这种治疗方法尚未在荟萃分析中进行评估。本综述的目的是评价与关节内注射皮质类固醇相比,关节内注射臭氧对减轻膝关节骨性关节炎患者疼痛和改善功能的有效性。使用PubMed、EMBASE、Central Cochrane和Web of Science电子数据库进行在线搜索,比较关节内注射臭氧和关节内注射皮质类固醇治疗膝关节骨关节炎的对照临床试验。本综述纳入了7项临床试验,共收集了409例膝关节骨关节炎患者。在综合分析中,臭氧注射被发现在减轻短期和中期疼痛方面比皮质类固醇注射更有效。同样,在中期观察到有利于臭氧注入的功能改善。我们的研究结果表明,臭氧注射是一个很好的替代皮质类固醇注射,以减轻短期和中期疼痛的个体与膝骨关节炎。然而,由于纳入研究的质量有限,无法得出明确的结论。需要更高质量的临床试验来加强证据并确认这些结果。
{"title":"Ozone injections reduce pain in knee osteoarthritis: a systematic review and meta-analysis.","authors":"Pedro Iván Arias-Vázquez, Rosa Giannina Castillo-Avila, Karen Hernández-Gil, Mauro Nicolás Guzzardo, Duilio Román Guzzardo","doi":"10.4103/mgr.MEDGASRES-D-25-00088","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00088","url":null,"abstract":"<p><p>The only intra-articular injections recommended by international guidelines for the treatment of knee osteoarthritis are injections of corticosteroids and hyaluronic acid; nonetheless, other substances including ozone, dextrose and platelet-rich plasma are also used in clinical. Intra-articular injections of ozone have been reported to have anti-inflammatory mechanisms and clinical benefits similar to intra-articular injections of corticosteroids in patients with knee osteoarthritis; however, this treatment has not been evaluated in a meta-analysis. The objective of this review is to evaluate the effectiveness of intra-articular injections of ozone for reducing pain and improving function in individuals with knee osteoarthritis when compared with intra-articular injections of corticosteroids. An online search was performed using the electronic databases PubMed, EMBASE, Central Cochrane and Web of Science, for controlled clinical trials that compared intra-articular injections of ozone and intra-articular injections of corticosteroid in the treatment of knee osteoarthritis. Seven clinical trials were included in this review, gathering 409 individuals with knee osteoarthritis. In the pooled analysis, ozone injections were found to be more effective in reducing pain in the short and medium terms than corticosteroids injections. Similarly, function improvement in the medium term was observed in favor of ozone injections. Our results suggest that ozone injections represent a good alternative to corticosteroids injections for reducing pain in the short and medium terms in individuals with knee osteoarthritis. Nonetheless, definitive conclusions could not be drawn due to the limited quality of the included studies. Better quality clinical trials are needed to strengthen the evidence and confirm these results.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 3","pages":"286-292"},"PeriodicalIF":2.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-08-18DOI: 10.4103/mgr.MEDGASRES-D-25-00065
Alejandro Fernandez-Cisneros
{"title":"Decompression sickness type II and patent foramen ovale: when a common congenital anomaly becomes a life-threatening risk.","authors":"Alejandro Fernandez-Cisneros","doi":"10.4103/mgr.MEDGASRES-D-25-00065","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00065","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 2","pages":"184-185"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144874050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-08-18DOI: 10.4103/mgr.MEDGASRES-D-25-00111
Michael C Wiest
{"title":"Old theory, new evidence: inhalational anesthetics disrupt a collective quantum state of intraneuronal microtubules to cause unconsciousness.","authors":"Michael C Wiest","doi":"10.4103/mgr.MEDGASRES-D-25-00111","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00111","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"16 2","pages":"182-183"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144874076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}